Bride Show Dubai is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa

Packages and pricing

A pass for every visitor

Eyebrow Text

Heading

Online

28th Sep    12:30 pm

Webinar
Sustainablitity Strategies in the Life Sciences Industries
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.
SPEAKERS
DISCUSSION POINTS
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
TALK SPONSOR

28th Sep

Webinar
Sourcing responsibly - putting ESG principles into practice
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.
SPEAKERS
DISCUSSION POINTS
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
TALK SPONSOR

28th Sep

Webinar
Improving scope 3 emission data quality to drive the decarbonization of our supply chains
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.